NAYA Biosciences, under the guidance of Dr. Daniel Teper, is carving a distinct path in the biotech industry by strategically embracing the portfolio model to focus on oncology, fertility, and regenerative medicine.  NAYA stands out for its approach of leveraging strategic acquisitions and interdisciplinary expertise to address unmet medical needs. This article examines the formation […]

The post NAYA Biosciences and Dr. Daniel Teper: Charting New Paths in Biotech Innovation appeared first on TechBullion.